We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.28B
Cap. Flow %
-1.24%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Financials 14.64%
3 Healthcare 13.3%
4 Consumer Discretionary 10.29%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TUP
2476
DELISTED
Tupperware Brands Corporation
TUP
$1.74M ﹤0.01%
202,842
-1,318
-0.6% -$14.4K
ULH icon
2477
Universal Logistics Holdings
ULH
$529M
$1.74M ﹤0.01%
91,650
-30,440
-25% -$635K
CHMA
2478
DELISTED
Chiasma, Inc. Common Stock
CHMA
$1.73M ﹤0.01%
348,499
-68,049
-16% -$354K
MMU
2479
Western Asset Managed Municipals Fund
MMU
$554M
$1.73M ﹤0.01%
129,734
DO
2480
DELISTED
Diamond Offshore Drilling
DO
$1.73M ﹤0.01%
240,123
-11,941
-5% -$69.4K
BE icon
2481
Bloom Energy
BE
$64.6B
$1.72M ﹤0.01%
230,873
-4,186
-2% -$20.3K
ADMS
2482
DELISTED
Adamas Pharmaceuticals
ADMS
$1.72M ﹤0.01%
454,062
+242,583
+115% +$1.16M
BLBD icon
2483
Blue Bird Corp
BLBD
$2.18B
$1.72M ﹤0.01%
74,979
+9,978
+15% +$199K
NOVA
2484
DELISTED
Sunnova Energy
NOVA
$1.72M ﹤0.01%
153,831
+118,830
+340% +$1.24M
PDLI
2485
DELISTED
PDL BioPharma, Inc.
PDLI
$1.7M ﹤0.01%
524,657
-1,647
-0.3% -$4.78K
ALTA
2486
DELISTED
Altabancorp
ALTA
$1.7M ﹤0.01%
56,526
-865
-2% -$25.4K
CHUY
2487
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$1.7M ﹤0.01%
65,566
-82,700
-56% -$2.14M
ZEUS
2488
DELISTED
Olympic Steel
ZEUS
$1.7M ﹤0.01%
94,773
-1,700
-2% -$27K
KRTX
2489
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.7M ﹤0.01%
+22,493
New +$985K
BSTC
2490
DELISTED
BioSpecifics Technologies Corp.
BSTC
$1.69M ﹤0.01%
29,661
-18,318
-38% -$971K
PSNL icon
2491
Personalis
PSNL
$1.51B
$1.68M ﹤0.01%
154,210
+12,137
+9% +$126K
SRNE
2492
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1.68M ﹤0.01%
497,324
-44,864
-8% -$107K
ARGX icon
2493
argenx
ARGX
$54.1B
$1.68M ﹤0.01%
10,469
-696
-6% -$94.1K
PGEN icon
2494
Precigen
PGEN
$2.59B
$1.68M ﹤0.01%
305,879
+14,450
+5% +$81.3K
IRMD icon
2495
iRadimed
IRMD
$1.18B
$1.67M ﹤0.01%
71,511
-3
-0% -$70
DVAX
2496
DELISTED
Dynavax Technologies
DVAX
$1.66M ﹤0.01%
290,189
-9,666
-3% -$51.7K
DOMO icon
2497
Domo
DOMO
$184M
$1.65M ﹤0.01%
76,189
-1,825
-2% -$33.7K
GEF.B icon
2498
Greif Class B
GEF.B
$4.21B
$1.65M ﹤0.01%
31,860
+6,558
+26% +$325K
DSM
2499
BNY Mellon Strategic Municipal Bond Fund
DSM
$293M
$1.64M ﹤0.01%
205,785
FMNB icon
2500
Farmers National Banc Corp
FMNB
$930M
$1.64M ﹤0.01%
100,251
-4,589
-4% -$70K

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.